End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
9.84 CNY | +4.79% | +6.72% | -10.55% |
Apr. 29 | Getein Biotech, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 29 | Getein Biotech, Inc Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 1.82B 252M | Sales 2023 | 1.37B 190M | Capitalization | 5.58B 773M |
---|---|---|---|---|---|
Net income 2022 | 499M 69.13M | Net income 2023 | 280M 38.79M | EV / Sales 2022 | 3.17 x |
Net cash position 2022 | 566M 78.47M | Net cash position 2023 | 270M 37.35M | EV / Sales 2023 | 3.88 x |
P/E ratio 2022 |
12.8
x | P/E ratio 2023 |
20
x | Employees | 2,508 |
Yield 2022 |
2.72% | Yield 2023 |
-
| Free-Float | 52.62% |
1 day | +4.79% | ||
1 week | +6.72% | ||
Current month | +4.79% | ||
1 month | +4.68% | ||
3 months | +22.85% | ||
6 months | -14.06% | ||
Current year | -10.55% |
Managers | Title | Age | Since |
---|---|---|---|
En Ben Su
CEO | Chief Executive Officer | 58 | 02-03-07 |
Wen Ni
DFI | Director of Finance/CFO | 41 | 12-12-31 |
Gang Zhu
BRD | Director/Board Member | 38 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
En Ben Su
CEO | Chief Executive Officer | 58 | 02-03-07 |
Bin Yan
BRD | Director/Board Member | 42 | 09-12-31 |
En Kui Su
BRD | Director/Board Member | 62 | 01-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 12 M€ | -16.71% | - | |
0.00% | 117 M€ | +3.12% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 9.84 | +4.79% | 9,933,920 |
24-04-30 | 9.39 | +1.84% | 5,279,983 |
End-of-day quote Shanghai S.E., May 05, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-10.55% | 658M | |
-1.19% | 12.56B | |
-6.06% | 7.68B | |
-0.28% | 5.29B | |
+21.79% | 5.24B | |
+2.05% | 4.57B | |
-51.30% | 3.29B | |
+7.80% | 2.6B | |
-8.63% | 2.2B | |
-0.96% | 1.79B |
- Stock Market
- Equities
- 603387 Stock